Pharmaceuticals

A notable trend in the Nanomedicine Drug Delivery Market is the advancement of AI-powered platforms enhancing precision drug delivery

March 23, 2026March 23, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Nanomedicine Drug Delivery Market By 2030 Starting From Its 2026 Size?

The nanomedicine drug delivery market size has experienced considerable expansion in recent years. It is forecast to grow from $123.37 billion in 2025 to $142.7 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.7%. The market’s past growth can be attributed to progress in nanotechnology research, the increasing occurrence of chronic diseases, the broadening scope of oncology drug development, a rise in academic nanomedicine investigations, and the initial successful clinical results of nanoformulations.

The nanomedicine drug delivery market is projected for significant expansion in the coming years, with its valuation anticipated to reach $252.69 billion by 2030, growing at a robust compound annual growth rate (CAGR) of 15.4%. This forecast expansion is driven by increasing investments in precision therapeutics, rising demand for targeted drug delivery, the expansion of nanomedicine clinical trials, growing integration of AI in formulation design, and increasing regulatory clarity for nanodrugs. Major trends influencing this period include the increasing development of targeted nanocarrier systems, rising use of liposomal drug delivery platforms, growing adoption of stimuli-responsive nanomaterials, expansion of oncology-focused nanomedicine applications, and an enhanced focus on drug bioavailability improvement.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29132&type=smp

What Drivers Are Shaping The Future Growth Of The Nanomedicine Drug Delivery Market?

The increasing integration of personalized medicine is anticipated to fuel expansion within the nanomedicine drug delivery market in the coming years. Personalized medicine is defined as a medical methodology that tailors treatment and preventive measures to the distinct attributes of individual patients, including their genetic makeup or specific disease classification. The uptake of personalized medicine is on the rise, driven by genomic and molecular advancements that facilitate treatments specifically designed for an individual’s genetic profile, thereby boosting efficacy and enabling highly accurate, focused interventions. Nanomedicine drug delivery plays a crucial role in personalized medicine by accurately guiding drugs to specific target cells and adapting dosages and formulations for every patient, consequently improving treatment success and mitigating adverse reactions. For example, in February 2024, as reported by the Personalized Medicine Coalition, an international non-profit organization based in the US, the US Food and Drug Administration (FDA) cleared 16 novel personalized treatments for individuals with rare conditions in 2023, an increase from six approvals documented in 2022. Consequently, the increasing embrace of personalized medicine is a key impetus behind the expansion of the nanomedicine drug delivery market.

Which Segment Categories Define The Nanomedicine Drug Delivery Market?

The nanomedicine drug delivery market covered in this report is segmented –

1) By Product Type: Nanoparticles, Liposomes, Micelles, Dendrimers, Nanotubes, Other Product Types

2) By Route Of Administration: Oral, Injectable, Topical, Other Routes Of Administration

3) By Application: Oncology, Cardiovascular Diseases, Neurology, Infectious Diseases, Other Applications

4) By End-User: Hospitals, Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Nanoparticles: Polymeric Nanoparticles, Metallic Nanoparticles, Lipid-Based Nanoparticles, Magnetic Nanoparticles, Quantum Dots

2) By Liposomes: Conventional Liposomes, Stealth Liposomes, Cationic Liposomes, Anionic Liposomes, pH-Sensitive Liposomes

3) By Micelles: Polymeric Micelles, Lipid Micelles, Amphiphilic Block Copolymer Micelles, Stimuli-Responsive Micelles, Mixed Micelles

4) By Dendrimers: Polyamidoamine Dendrimers, Polypropylene Imine Dendrimers, Peptide Dendrimers, Carbohydrate Dendrimers, Hydroxyl-Terminated Dendrimers

5) By Nanotubes: Carbon Nanotubes, Peptide Nanotubes, Inorganic Nanotubes, Multi-Walled Nanotubes, Single-Walled Nanotubes

6) By Other Product Types: Nanospheres, Nanocapsules, Nanoemulsions, Nanogels, Hybrid Nanocarrier

What Major Market Trends Are Driving Changes In The Nanomedicine Drug Delivery Market?

Major companies in the nanomedicine drug delivery market are concentrating on developing drug delivery solutions, including AI-powered nano-delivery platforms, to enhance targeting precision and accelerate the development of personalized treatments. These AI-powered nano-delivery platforms represent cutting-edge systems that utilize artificial intelligence to design and optimize nanoparticles for precise drug targeting, thereby improving therapeutic outcomes, minimizing side effects, and enabling personalized treatment. As an illustration, in September 2025, METiS TechBio, a China-based biotechnology company, launched NanoForge, an AI-driven nano-delivery platform designed to revolutionize the way medicines are developed and delivered. This system integrates artificial intelligence with nanotechnology to optimize lipid nanoparticle formulations and deliver drugs accurately to target tissues, facilitating faster, safer, and more cost-effective drug development. This innovation aims to overcome significant barriers in drug delivery for complex molecules such as mRNA, moving the field toward programmable and reconfigurable therapeutics.

Who Are The Top Companies Competing In The Nanomedicine Drug Delivery Market?

Major companies operating in the nanomedicine drug delivery market are Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences Inc., Evonik Industries AG, Ipsen Pharma S.A.S., Pacira BioSciences Inc., Camurus AB, Arcturus Therapeutics Holdings Inc., Nanobiotix S.A., Acuitas Therapeutics Inc., NanoViricides Inc., Taiwan Liposome Company Ltd., Aphios Corporation, Concept Medical Inc., DelSiTech Ltd., ANP Technologies Inc., ProMab Biotechnologies Inc., BlueWillow Biologics Inc., Nanoform Finland Plc.

Read the full nanomedicine drug delivery market report here:

https://www.thebusinessresearchcompany.com/report/nanomedicine-drug-delivery-global-market-report

Which Geographic Regions Are Influencing Demand In The Nanomedicine Drug Delivery Market?

North America was the largest region in the nanomedicine drug delivery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomedicine drug delivery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Nanomedicine Drug Delivery Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=29132&type=smp

Browse Through More Reports Similar to the Global Nanomedicine Drug Delivery Market 2026, By The Business Research Company

Nanomedicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795